Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
[1] RARA 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
2 Adherens junction 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
3 Adherens junction 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
4 Adipocytokine signaling pathway 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
5 Adipocytokine signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
6 African trypanosomiasis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
7 African trypanosomiasis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
9 Alcoholic liver disease 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
10 Alcoholic liver disease 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
11 Alcoholic liver disease 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
12 Alcoholic liver disease 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
13 Alcoholic liver disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
14 Allograft rejection 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
15 Allograft rejection 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
16 Allograft rejection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
17 Alzheimer disease 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
18 Alzheimer disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
19 Amoebiasis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
20 Amoebiasis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
21 Amphetamine addiction 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
22 AMPK signaling pathway 💬
[1] HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
23 AMPK signaling pathway 💬
[1] HMGCR 💬 Atorvastatin 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
24 AMPK signaling pathway 💬
[1] HMGCR 💬 Lovastatin 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
25 AMPK signaling pathway 💬
[1] HMGCR 💬 Simvastatin 💬 Simvastatin [22]  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
26 Amyotrophic lateral sclerosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
27 Amyotrophic lateral sclerosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
28 Antigen processing and presentation 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
29 Apoptosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
30 Arachidonic acid metabolism 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
31 Asthma 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
32 Autoimmune thyroid disease 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
33 Axon guidance 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
34 B cell receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
35 Bile secretion 💬
[1] HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
36 Bile secretion 💬
[1] HMGCR 💬 Atorvastatin 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
37 Bile secretion 💬
[1] HMGCR 💬 Lovastatin 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
38 Bile secretion 💬
[1] HMGCR 💬 Simvastatin 💬 Simvastatin [22]  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
39 Bladder cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
40 Bladder cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
41 Breast cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
42 Breast cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
43 C-type lectin receptor signaling pathway 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
44 C-type lectin receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
45 C-type lectin receptor signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
46 Cadherin signaling 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
47 Cadherin signaling 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
48 Calcium signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
49 Calcium signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
50 Calcium signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
51 cAMP signaling pathway 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
52 Cell adhesion molecule (CAM) interaction 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
53 Cellular senescence 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
54 Central carbon metabolism in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
55 Central carbon metabolism in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
56 cGMP-PKG signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
57 Chagas disease 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
58 Chagas disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
59 Chemical carcinogenesis - reactive oxygen species 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
60 Chemical carcinogenesis - reactive oxygen species 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
61 Chemical carcinogenesis - receptor activation 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
62 Chemical carcinogenesis - receptor activation 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
63 Chemical carcinogenesis - receptor activation 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
64 Choline metabolism in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
65 Choline metabolism in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
66 Colorectal cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
67 Colorectal cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
68 Coronavirus disease 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
69 Coronavirus disease 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
70 Coronavirus disease 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
71 Coronavirus disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
72 Coronavirus disease 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
73 Cushing syndrome 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
74 Cushing syndrome 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
75 Cytokine-cytokine receptor interaction 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
76 Cytokine-cytokine receptor interaction 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
77 Cytokine-cytokine receptor interaction 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
78 Cytokine-cytokine receptor interaction 💬
[1] IL1RL2 💬 Spesolimab 💬 Spesolimab [5] 37, 96, 97, 160, 269 💬
79 Cytokine-cytokine receptor interaction 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
80 Cytokine-cytokine receptor interaction 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
81 Diabetic cardiomyopathy 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
82 Dilated cardiomyopathy 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
83 Dopaminergic synapse 💬
[3] PPP3CA, PPP3CB, PPP3CC 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
84 Efferocytosis 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
85 Endocytosis 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
86 Endocytosis 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
87 Endometrial cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
88 Endometrial cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
89 Epithelial cell signaling in Helicobacter pylori infection 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
90 Epithelial cell signaling in Helicobacter pylori infection 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
91 Epstein-Barr virus infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
92 Epstein-Barr virus infection 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
93 ErbB signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
94 ErbB signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
95 Estrogen signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
96 Estrogen signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
97 Estrogen signaling pathway 💬
[1] RARA 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
98 Fc epsilon RI signaling pathway 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
99 Fc epsilon RI signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
100 Fluid shear stress and atherosclerosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
101 Focal adhesion 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
102 Focal adhesion 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
103 FoxO signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
104 FoxO signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
105 Gap junction 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
106 Gap junction 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
107 Gastric cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
108 Gastric cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
109 Gastric cancer 💬
[1] RARB 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
110 Glioma 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
111 Glioma 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
112 Glucagon signaling pathway 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
113 Glucagon signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
114 Glutamatergic synapse 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
115 GnRH signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
116 GnRH signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
117 Graft-versus-host disease 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
118 Graft-versus-host disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
119 Hematopoietic cell lineage 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
120 Hematopoietic cell lineage 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
121 Hepatitis B 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
122 Hepatitis B 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
123 Hepatitis C 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
124 Hepatitis C 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
125 Hepatitis C 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
126 Hepatitis C 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
127 Hepatitis C 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
128 Hepatocellular carcinoma 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
129 Hepatocellular carcinoma 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
130 Herpes simplex virus 1 infection 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
131 Herpes simplex virus 1 infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
132 Herpes simplex virus 1 infection 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
133 HIF-1 signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
134 HIF-1 signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
135 Human cytomegalovirus infection 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
136 Human cytomegalovirus infection 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
137 Human cytomegalovirus infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
138 Human cytomegalovirus infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
139 Human immunodeficiency virus 1 infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
140 Human immunodeficiency virus 1 infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
141 Human papillomavirus infection 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
142 Human papillomavirus infection 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
143 Human papillomavirus infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
144 Human papillomavirus infection 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
145 Human T-cell leukemia virus 1 infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
146 Human T-cell leukemia virus 1 infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
147 Hypertrophic cardiomyopathy 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
148 IgSF CAM signaling 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
149 IL-17 signaling pathway 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
150 IL-17 signaling pathway 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
151 IL-17 signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
152 Inflammatory bowel disease 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
153 Inflammatory bowel disease 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
154 Inflammatory bowel disease 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
155 Inflammatory bowel disease 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
156 Inflammatory bowel disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
157 Influenza A 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
158 Influenza A 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
159 Influenza A 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
160 Insulin resistance 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
161 Insulin resistance 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
162 Integrin signaling 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
163 Integrin signaling 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
164 Intestinal immune network for IgA production 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
165 JAK-STAT signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
166 JAK-STAT signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
167 JAK-STAT signaling pathway 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
168 JAK-STAT signaling pathway 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
169 JAK-STAT signaling pathway 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
170 Kaposi sarcoma-associated herpesvirus infection 💬
[1] CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
171 Kaposi sarcoma-associated herpesvirus infection 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
172 Kaposi sarcoma-associated herpesvirus infection 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
173 Legionellosis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
174 Legionellosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
175 Leishmaniasis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
176 Leishmaniasis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
177 Lipid and atherosclerosis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
178 Lipid and atherosclerosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
179 Lipid and atherosclerosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
180 Long-term potentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
181 Malaria 💬
[1] IL12A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
182 Malaria 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
183 MAPK signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
184 MAPK signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
185 MAPK signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
186 MAPK signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
187 Measles 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
188 Measles 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
189 Melanoma 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
190 Melanoma 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
191 MicroRNAs in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
192 MicroRNAs in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
193 mTOR signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
194 Natural killer cell mediated cytotoxicity 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
195 Natural killer cell mediated cytotoxicity 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
196 Necroptosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
197 Necroptosis 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
198 NF-kappa B signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
199 NOD-like receptor signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
200 NOD-like receptor signaling pathway 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
201 Non-alcoholic fatty liver disease 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
202 Non-alcoholic fatty liver disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
203 Non-small cell lung cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
204 Non-small cell lung cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
205 Non-small cell lung cancer 💬
[1] RARB 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
206 Oocyte meiosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
207 Osteoclast differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
208 Osteoclast differentiation 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
209 Osteoclast differentiation 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
210 Ovarian steroidogenesis 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
211 Oxytocin signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
212 Oxytocin signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
213 Oxytocin signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
214 Pancreatic cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
215 Pancreatic cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
216 Parathyroid hormone synthesis, secretion and action 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
217 Parathyroid hormone synthesis, secretion and action 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
218 Pathogenic Escherichia coli infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
219 Pathways in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
220 Pathways in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
221 Pathways in cancer 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
222 Pathways in cancer 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
223 Pathways in cancer 💬
[2] RARA, RARB 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
224 Pathways of neurodegeneration - multiple diseases 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
225 Pathways of neurodegeneration - multiple diseases 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
226 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
227 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
228 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
229 Pertussis 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
230 Pertussis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
231 Phospholipase D signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
232 Phospholipase D signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
233 PI3K-Akt signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
234 PI3K-Akt signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
235 PI3K-Akt signaling pathway 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
236 PPAR signaling pathway 💬
[1] PPARA 💬 Bezafibrate 💬 Bezafibrate [8] 20, 93, 94, 160, 296, 316, 324, 344 💬
237 Prion disease 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
238 Prion disease 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
239 Prostate cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
240 Prostate cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
241 Proteoglycans in cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
242 Proteoglycans in cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
243 Proteoglycans in cancer 💬
[1] IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
244 Proteoglycans in cancer 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
245 Rap1 signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
246 Rap1 signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
247 Ras signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
248 Ras signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
249 Regulation of actin cytoskeleton 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
250 Regulation of actin cytoskeleton 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
251 Relaxin signaling pathway 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
252 Relaxin signaling pathway 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
253 Renin secretion 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
254 Rheumatoid arthritis 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
255 Rheumatoid arthritis 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
256 Rheumatoid arthritis 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
257 Rheumatoid arthritis 💬
[1] IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
258 Rheumatoid arthritis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
259 RIG-I-like receptor signaling pathway 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
260 RIG-I-like receptor signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
261 Salmonella infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
262 Serotonergic synapse 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
263 Shigellosis 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
264 Shigellosis 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
265 Shigellosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
266 Small cell lung cancer 💬
[1] RARB 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
267 Sphingolipid signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
268 Systemic lupus erythematosus 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
269 Systemic lupus erythematosus 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
270 T cell receptor signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
271 T cell receptor signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
272 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
273 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 Atorvastatin 💬 Atorvastatin [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
274 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 Lovastatin 💬 Lovastatin [11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
275 Terpenoid backbone biosynthesis 💬
[1] HMGCR 💬 Simvastatin 💬 Simvastatin [22]  6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
276 TGF-beta signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
277 Th1 and Th2 cell differentiation 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
278 Th1 and Th2 cell differentiation 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
279 Th1 and Th2 cell differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
280 Th1 and Th2 cell differentiation 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
281 Th17 cell differentiation 💬
[1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
282 Th17 cell differentiation 💬
[1] IL17A 💬 Secukinumab 💬 Secukinumab [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
283 Th17 cell differentiation 💬
[1] IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
284 Th17 cell differentiation 💬
[1] IL4R 💬 Dupilumab 💬 Dupilumab [8] 51, 97, 98, 160, 162, 222, 300, 306 💬
285 Th17 cell differentiation 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
286 Th17 cell differentiation 💬
[1] RARA 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
287 Th17 cell differentiation 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
288 TNF signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
289 Toll-like receptor signaling pathway 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
290 Toll-like receptor signaling pathway 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
291 Toll-like receptor signaling pathway 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
292 Toll-like receptor signaling pathway 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
293 Toxoplasmosis 💬
[1] ALOX5 💬 Zileuton 💬 Zileuton [3] 85, 160, 164 💬
294 Toxoplasmosis 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
295 Toxoplasmosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
296 Toxoplasmosis 💬
[1] TYK2 💬 Deucravacitinib 💬 Deucravacitinib [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
297 Transcriptional misregulation in cancer 💬
[1] CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
298 Transcriptional misregulation in cancer 💬
[1] RARA 💬 Isotretinoin 💬 Isotretinoin [4] 36, 39, 159, 160 💬
299 Tuberculosis 💬
[3] IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
300 Tuberculosis 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
301 Tuberculosis 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
302 Type I diabetes mellitus 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
303 Type I diabetes mellitus 💬
[2] IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
304 Type I diabetes mellitus 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
305 Type II diabetes mellitus 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
306 VEGF signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
307 Viral myocarditis 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
308 Viral protein interaction with cytokine and cytokine receptor 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
309 Virion - Adenovirus 💬
[2] CD80, CD86 💬 Abatacept 💬 Abatacept [28]  2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
310 Virion - Hepatitis viruses 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
311 Virion - Hepatitis viruses 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
312 Wnt signaling pathway 💬
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus [1] 160 💬
313 Yersinia infection 💬
[1] TNF 💬 Adalimumab 💬 Adalimumab [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬